121 related articles for article (PubMed ID: 12924217)
21. [Transdermal therapeutic systems].
Losenkova SO
Eksp Klin Farmakol; 2008; 71(6):54-7. PubMed ID: 19140519
[TBL] [Abstract][Full Text] [Related]
22. Nanoscale analysis of protein and peptide absorption: insulin absorption using complexation and pH-sensitive hydrogels as delivery vehicles.
Peppas NA; Kavimandan NJ
Eur J Pharm Sci; 2006 Nov; 29(3-4):183-97. PubMed ID: 16777391
[TBL] [Abstract][Full Text] [Related]
23. Microemulsion-based hydrogel formulation of ibuprofen for topical delivery.
Chen H; Chang X; Du D; Li J; Xu H; Yang X
Int J Pharm; 2006 Jun; 315(1-2):52-8. PubMed ID: 16600540
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of transdermal delivery of theophylline using microemulsion vehicle.
Zhao X; Liu JP; Zhang X; Li Y
Int J Pharm; 2006 Dec; 327(1-2):58-64. PubMed ID: 16926077
[TBL] [Abstract][Full Text] [Related]
25. Pilot study of topical delivery of methotrexate by electroporation.
Wong TW; Zhao YL; Sen A; Hui SW
Br J Dermatol; 2005 Mar; 152(3):524-30. PubMed ID: 15787822
[TBL] [Abstract][Full Text] [Related]
26. Topical iodine facilitates transdermal delivery of insulin.
Sintov AC; Wormser U
J Control Release; 2007 Apr; 118(2):185-8. PubMed ID: 17270303
[TBL] [Abstract][Full Text] [Related]
27. Transdermal delivery of a pineal hormone: melatonin via elastic liposomes.
Dubey V; Mishra D; Asthana A; Jain NK
Biomaterials; 2006 Jun; 27(18):3491-6. PubMed ID: 16513163
[TBL] [Abstract][Full Text] [Related]
28. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption.
Morishita M; Goto T; Peppas NA; Joseph JI; Torjman MC; Munsick C; Nakamura K; Yamagata T; Takayama K; Lowman AM
J Control Release; 2004 May; 97(1):115-24. PubMed ID: 15147809
[TBL] [Abstract][Full Text] [Related]
29. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles.
Li G; Badkar A; Nema S; Kolli CS; Banga AK
Int J Pharm; 2009 Feb; 368(1-2):109-15. PubMed ID: 18996461
[TBL] [Abstract][Full Text] [Related]
30. Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems.
Sintov AC; Botner S
Int J Pharm; 2006 Mar; 311(1-2):55-62. PubMed ID: 16431047
[TBL] [Abstract][Full Text] [Related]
31. Complexation hydrogels for oral protein delivery: an in vitro assessment of the insulin transport-enhancing effects following dissolution in simulated digestive fluids.
Perakslis E; Tuesca A; Lowman A
J Biomater Sci Polym Ed; 2007; 18(12):1475-90. PubMed ID: 17988515
[TBL] [Abstract][Full Text] [Related]
32. Enhanced transdermal delivery of a dipeptide by dermaportation.
Namjoshi S; Chen Y; Edwards J; Benson HA
Biopolymers; 2008; 90(5):655-62. PubMed ID: 18536044
[TBL] [Abstract][Full Text] [Related]
33. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery.
Kumar A; Lahiri SS; Singh H
Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246
[TBL] [Abstract][Full Text] [Related]
34. A solid-in-oil nanodispersion for transcutaneous protein delivery.
Tahara Y; Honda S; Kamiya N; Piao H; Hirata A; Hayakawa E; Fujii T; Goto M
J Control Release; 2008 Oct; 131(1):14-8. PubMed ID: 18687370
[TBL] [Abstract][Full Text] [Related]
35. Use of sorption promoters to increase systemic absorption of coumarin from transdermal drug delivery systems.
Ritschel WA; Barkhaus JK
Arzneimittelforschung; 1988 Dec; 38(12):1774-7. PubMed ID: 3245850
[TBL] [Abstract][Full Text] [Related]
36. Effect of chemical enhancers on percutaneous absorption of daphnetin in isopropyl myristate vehicle across rat skin in vitro.
Wen Z; Fang L; He Z
Drug Deliv; 2009 May; 16(4):214-23. PubMed ID: 19280376
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of promoting effect of several transdermal enhancers with fuzzy matter-element model].
Zheng X; Wang H; Cheng K; Liang Q
Zhongguo Zhong Yao Za Zhi; 2009 Oct; 34(20):2599-603. PubMed ID: 20069900
[TBL] [Abstract][Full Text] [Related]
38. Extended release of lidocaine from linker-based lecithin microemulsions.
Yuan JS; Acosta EJ
Int J Pharm; 2009 Feb; 368(1-2):63-71. PubMed ID: 19010404
[TBL] [Abstract][Full Text] [Related]
39. [Transdermal therapeutic systems for drug administration].
Hupfeld S; Gravem H
Tidsskr Nor Laegeforen; 2009 Mar; 129(6):532-3. PubMed ID: 19282891
[TBL] [Abstract][Full Text] [Related]
40. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
